It can provide a therapeutic solution not only for pathological conditions but also for early-stage symptoms where conventional medicine is unable to provide chemical medications, such as: Psychosomatic Symptoms Neurovegetative Symptoms Non-specific symptoms It is considered necessary for the patient with psychosomatic symptoms, chronic, or autoimmune diseases, in order to achieve better therapeutic outcomes, to discuss other treatment options with their attending physician, such as Modern Homeopathic Treatment
Amgen, Pfizer, and Viking Therapeutics are developing competitors
Accelerated Healing Processes: Beneficial for recovery from both cosmetic procedures and unintentional skin injuries
Healthy sleep practices for shift workers: consensus sleep hygiene guidelines using a Delphi methodology
To learn more about GLP-1 agonists, including their benefits and potential side effects, feel free to read on
Novo Nordisk has indicated a phased UK rollout in the second half of 2026, initially through private prescription, and it is not yet available on the NHS